Literature DB >> 7954588

Ischaemic preconditioning protects hypertrophied myocardium.

M E Speechly-Dick1, G F Baxter, D M Yellon.   

Abstract

OBJECTIVE: Clinical and experimental evidence suggests that hypertrophied myocardium is more susceptible to injury from ischaemia than normal myocardium. This study was designed to investigate whether preconditioning confers protection on hearts with moderate hypertrophy.
METHODS: Cardiac hypertrophy induced by hypertension was produced in rats by giving saline drinking fluid and subcutaneous deoxycorticosterone acetate for four weeks. After thoracotomy, localisation of the left main coronary artery and stabilisation, groups of hypertensive animals with cardiac hypertrophy (HT) and their age matched normotensive controls (NT) underwent a preconditioning protocol consisting of 5 min occlusion of the left main coronary artery followed by 10 min reperfusion. This was followed by 45 min ischaemia and at least 2.5 h reperfusion. Control animals in the hypertrophied and normotensive groups were treated identically but were not subjected to the preconditioning protocol. Thus there were four experimental groups: HT preconditioned (n = 8), HT control (n = 7), NT preconditioned (n = 7), and NT control (n = 7). Infarct size was measured using triphenyl tetrazolium chloride and was expressed as a percentage of the volume at risk, measured with fluorescent particles.
RESULTS: Heart weight was greater (p < 0.01) in the HT groups than in the NT groups [HT preconditioned 1.7(SEM 0.06) g, HT control 1.71(0.02) g, NT preconditioned 1.3(0.04) g, NT control 1.31(0.03) g]. Infarct to risk volume ratio (I/R) was significantly lower (p < 0.05) in the preconditioned groups as compared with controls [HT preconditioned 19.1(1.5)% v HT control 67.1(5.6)%, and NT preconditioned 33.4(5.5)% v NT control 77.1(3.8)%]. There was no significant difference in the volume at risk of infarction between the four groups.
CONCLUSIONS: Ischaemic preconditioning can induce myocardial protection in hypertrophied myocardium; this is the first study to demonstrate preconditioning in hypertrophy.

Entities:  

Mesh:

Year:  1994        PMID: 7954588     DOI: 10.1093/cvr/28.7.1025

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  15 in total

1.  Impaired cardiac ischemic tolerance in spontaneously hypertensive rats is attenuated by adaptation to chronic and acute stress.

Authors:  T Ravingerová; I Bernátová; J Matejíková; V Ledvényiová; M Nemčeková; O Pecháňová; N Tribulová; J Slezák
Journal:  Exp Clin Cardiol       Date:  2011

2.  Preconditioning: a balanced perspective.

Authors:  K Przyklenk; R A Kloner
Journal:  Br Heart J       Date:  1995-12

3.  Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts.

Authors:  C I Pantos; C H Davos; H C Carageorgiou; D V Varonos; D V Cokkinos
Journal:  Basic Res Cardiol       Date:  1996 Nov-Dec       Impact factor: 17.165

Review 4.  Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.

Authors:  Demetria M Fischesser; Bin Bo; Rachel P Benton; Haili Su; Newsha Jahanpanah; Kevin J Haworth
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-17       Impact factor: 2.457

Review 5.  Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice.

Authors:  D P Jenkins; S E Steare; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

Review 6.  Non-ischemic myocardial preconditioning.

Authors:  R Domenech; P Macho
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

Review 7.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

8.  Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats.

Authors:  L Piacentini; C L Wainwright; J R Parratt
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

Review 9.  Myocardial protection in man--from research concept to clinical practice.

Authors:  Dennis V Cokkinos; Costas Pantos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

10.  Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation.

Authors:  Jonas Agerlund Povlsen; Bo Løfgren; Christian Dalgas; Rune Isak Dupont Birkler; Mogens Johannsen; Nicolaj Brejnholt Støttrup; Hans Erik Bøtker
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.